Which treatment order works best for advanced kidney cancer?
NCT ID NCT07324876
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 860 Chinese patients with advanced kidney cancer to see which order of treatments works better: starting with one drug combo and switching to another, or the reverse. The goal is to find the best sequence to help patients live longer and feel better. Participants must have a specific risk level and no prior cancer treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RCC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill that starves tumors of oxygen help fight advanced cancer?
- Blood test may let cancer patients take safe breaks from immunotherapy
- New hope for advanced kidney cancer: first human trial of NEO-811 begins
- Blood test may spot kidney cancer return before scans do
- Can a higher dose of cabozantinib outsmart advanced kidney cancer?
- Engineered immune cells take on Hard-to-Treat cancers